» Articles » PMID: 34765301

Three Dimensional in Vitro Culture Systems in Anticancer Drug Discovery Targeted on Cancer Stem Cells

Overview
Journal Am J Cancer Res
Specialty Oncology
Date 2021 Nov 12
PMID 34765301
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Worldwide, tumors are one of the most common causes of death. Every year 3.7 million new cases occur in Europe and more than 1.9 million patients die (WHO data). Most of the fields of research are focused on developing new therapeutic strategies that will be effective in eliminating the tumor, preventing its remission, and avoiding or reducing the side effects of therapy. In the past, generally classical 2D cell cultures or immunodeficient animal models had been used to cultivate and test drugs on human cancer cell lines. Nowadays, there are increasing interests in three-dimensional (3D) cell cultures, a method with significant differences from flat cultured cells, both considering gene expressions and cell-cell interactions. Various evidence suggests that high tumorigenic properties might be dependent on the occurrence of a small cell population, pointed out to be responsible for metastasis and recurrence. This population is called cancer stem cells (CSCs), hinted to have a lot of similarities with normal stem cells. CSCs are the main reason for chemotherapy failure as well as multi-drug resistance (MDR). CSCs can also interact through the cytokine network, with other cells like the macrophages of the inflammatory system. The big advantage of a 3D culture is the possibility to isolate and investigate the CSCs population surrounded by its environment. This article aims to sum up known 3D cell cultures, especially in the field of CSCs research due to the importance of the tumor's environment on stem cell's markers expression and their development.

Citing Articles

Thermo-Responsive Hydrogel Based on Lung Decellularized Extracellular Matrix for 3D Culture Model to Enhance Cancer Stem Cell Characteristics.

Chen L, Li F, Li R, Zheng K, Zhang X, Ma H Molecules. 2024; 29(18).

PMID: 39339380 PMC: 11433703. DOI: 10.3390/molecules29184385.


Preclinical spheroid models identify BMX as a therapeutic target for metastatic MYCN nonamplified neuroblastoma.

Sundaramoorthy S, Colombo D, Sanalkumar R, Broye L, Balmas Bourloud K, Boulay G JCI Insight. 2024; 9(14).

PMID: 39133652 PMC: 11383371. DOI: 10.1172/jci.insight.169647.


Matrix Gla Protein drives stemness and tumor initiation in ovarian cancer.

Nieddu V, Melocchi V, Battistini C, Franciosa G, Lupia M, Stellato C Cell Death Dis. 2023; 14(3):220.

PMID: 36977707 PMC: 10050398. DOI: 10.1038/s41419-023-05760-w.

References
1.
Raghavan S, Mehta P, Xie Y, Lei Y, Mehta G . Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments. J Immunother Cancer. 2019; 7(1):190. PMC: 6642605. DOI: 10.1186/s40425-019-0666-1. View

2.
Toh Y, Zhang C, Zhang J, Khong Y, Chang S, Samper V . A novel 3D mammalian cell perfusion-culture system in microfluidic channels. Lab Chip. 2007; 7(3):302-9. DOI: 10.1039/b614872g. View

3.
Mehta P, Novak C, Raghavan S, Ward M, Mehta G . Self-Renewal and CSCs In Vitro Enrichment: Growth as Floating Spheres. Methods Mol Biol. 2017; 1692:61-75. PMC: 5925737. DOI: 10.1007/978-1-4939-7401-6_6. View

4.
De Francesco E, Sotgia F, Lisanti M . Cancer stem cells (CSCs): metabolic strategies for their identification and eradication. Biochem J. 2018; 475(9):1611-1634. PMC: 5941316. DOI: 10.1042/BCJ20170164. View

5.
Powley I, Patel M, Miles G, Pringle H, Howells L, Thomas A . Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery. Br J Cancer. 2020; 122(6):735-744. PMC: 7078311. DOI: 10.1038/s41416-019-0672-6. View